Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, Gurgaon, India, has announced that under an agreement with AstraZeneca Pharmaceuticals it has launched an authorized generic of Omeprazole 40mg capsules in the US healthcare system.
Ranbaxy’s Omeprazole 40mg is indicated for the treatment of acid-related disease, including gastric ulcer and Zollinger-Ellison syndrome.
Jim Meehan, vice president of sales and distribution at Ranbaxy Pharmaceuticals, said: “We welcome the opportunity to market an authorized generic of Omeprazole 40mg capsules that will be commercialized immediately to all classes of trade in the US healthcare system under the Ranbaxy label.
“We will offer this product as an affordable and accessible generic formulation to patients requiring this medication.”
Comments